Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
CARTICEL
Overview
What is CARTICEL?
Autologous cultured chondrocytes, the Carticel product, are derived from expansion of chondrocytes harvested from the patient's normal, femoral articular cartilage. Biopsies from a lesser-weight bearing area are the source of chondrocytes, which are isolated, expanded through cell culture, and implanted into articular cartilage defects beneath an autologous periosteal flap. Prior to final packaging, cell viability is assessed to be at least 80%.
Each single use container of autologous cultured chondrocytes has approximately 12 million cells aseptically processed and suspended in 0.4 mL of sterile, buffered Dulbecco's Modified Eagles Medium (DMEM). Both the biopsy transport media and the cell culture media contain gentamicin. Residual quantities of gentamicin up to 5 µg/mL may be present in the Carticel product.
What does CARTICEL look like?
What are the available doses of CARTICEL?
Each Carticel vial of autologous cultured chondrocytes contains approximately 12 million cells per vial. ()
What should I talk to my health care provider before I take CARTICEL?
Use in children or patients over age 65 has not been assessed. ()
How should I use CARTICEL?
Carticel is indicated for the repair of symptomatic cartilage defects of the femoral condyle (medial, lateral or trochlea), caused by acute or repetitive trauma, in patients who have had an inadequate response to a prior arthroscopic or other surgical repair procedure (e.g., debridement, microfracture, drilling/abrasion arthroplasty, or osteochondral allograft/autograft).
Carticel should be used only in conjunction with debridement, placement of a periosteal flap and rehabilitation. The independent contributions of the autologous cultured chondrocytes and other components of the therapy to outcome are unknown.
Carticel is not indicated for the treatment of cartilage damage associated with generalized osteoarthritis.
Carticel is not recommended for patients with total meniscectomy unless surgically reconstructed prior to or concurrent with Carticel implantation.
For Autologous Implantation Only
What interacts with CARTICEL?
Sorry No Records found
What are the warnings of CARTICEL?
Sorry No Records found
What are the precautions of CARTICEL?
Sorry No Records found
What are the side effects of CARTICEL?
Sorry No records found
What should I look out for while using CARTICEL?
Carticel should not be used in patients with a known history of hypersensitivity to gentamicin, other aminoglycosides or materials of bovine origin.
Gentamicin is added to both the cartilage biopsy transport media and in the culture media used during the processing of Carticel. Residual quantities of gentamicin up to 5 µg/mL are present in the Carticel product.
Fetal bovine serum is a component in the culture medium used to propagate the autologous chondrocytes. Trace quantities of bovine-derived proteins may be present in the Carticel product.
What might happen if I take too much CARTICEL?
Sorry No Records found
How should I store and handle CARTICEL?
The Carticel transport box should be held at room temperature and remain closed until the time of implantation to ensure proper storage conditions for the cells.Do Not Refrigerate, Freeze, or Incubate the Carticel Shipping Container or its Contents.Do Not Sterilize.If the Vial is Damaged or Sterility has been Compromised, Do Not Use.The Carticel transport box should be held at room temperature and remain closed until the time of implantation to ensure proper storage conditions for the cells.Do Not Refrigerate, Freeze, or Incubate the Carticel Shipping Container or its Contents.Do Not Sterilize.If the Vial is Damaged or Sterility has been Compromised, Do Not Use.The Carticel transport box should be held at room temperature and remain closed until the time of implantation to ensure proper storage conditions for the cells.Do Not Refrigerate, Freeze, or Incubate the Carticel Shipping Container or its Contents.Do Not Sterilize.If the Vial is Damaged or Sterility has been Compromised, Do Not Use.The Carticel transport box should be held at room temperature and remain closed until the time of implantation to ensure proper storage conditions for the cells.Do Not Refrigerate, Freeze, or Incubate the Carticel Shipping Container or its Contents.Do Not Sterilize.If the Vial is Damaged or Sterility has been Compromised, Do Not Use.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.PredniSONE Tablets USP1 mg, round, white, scored tablets (Identified 54 092)NDC 0615-6516-39: Blistercards of 30 tablets.2.5 mg, round, white, scored tablets (Identified 54 339)NDC 0615-2513-39: Blistercards of 30 tablets.5 mg, round, white, scored tablets (Identified 54 612)10 mg, round, white, scored tablets (Identified 54 899)20 mg, round, white, scored tablets (Identified 54 760)NDC 0615-1542-39: Blistercards of 30 tablets.50 mg, round, white, scored tablets (Identified 54 343)Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PROTECT FROM MOISTURE.PredniSONE Oral Solution USP, 5 mg per 5 mLClear, colorless solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense in a tight container, as defined in the USP/NF.PredniSONE Intensol™ Oral Solution (Concentrate), 5 mg per mLClear, colorless, slightly viscous solutionStore at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].Dispense only in the bottle and only with the calibrated dropper provided. Discard opened bottle after 90 days.
